Berlin Cures GmbH
Ingolf Schimke has completed his Ph.D. at the age of 27 years from “Academia der Wissenschaften” of the German Democratic Republic and postdoctoral studies from “Humbold Universität zu Berlin” Medicine. Until 2014, he was Professor for Clinical Chemistry and Laboratory Medicine at the “Charité – Universitätsmedizin Berlin” and is presently Director of Research & Development at “Berlin Cures GmbH”. He has published more than 100 papers in reputed journals. He is serving as an editorial board member of reputed journals.
autoantibodies, autoimmune diseases